• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从参与者的视角:在肯尼亚夸莱的BOHEMIA临床试验背景下,运用照片声音法理解伊维菌素大规模药物驱虫的经历及效果

Through the eyes of the participant: using photovoice to understand the experiences and effects of ivermectin MDA in the context of the BOHEMIA clinical trial in Kwale, Kenya.

作者信息

Onyango Truphena, Nuru Khadija, Kazungu Karisa, Wangari Winnie, Chaccour Carlos, Regina Rabinovich N, Mwangangi Joseph, Maia Marta, Jones Caroline

机构信息

Kenya Medical Research Institute, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya.

ISGlobal, Barcelona, Spain.

出版信息

Malar J. 2025 Mar 12;24(1):79. doi: 10.1186/s12936-025-05320-x.

DOI:10.1186/s12936-025-05320-x
PMID:40075477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11905568/
Abstract

BACKGROUND

Assessing the acceptability of new malaria control interventions in clinical trials can be complex due to the need for strict ethical standards and specific trial procedures. While in-depth interviews and focus group discussions can provide useful insights, a more participatory method of data collection which complements these methods is photovoice. Photovoice offers a unique approach, empowering participants to share their experiences and perceptions on their own terms. Photovoice was employed alongside the BOHEMIA clinical trial (a trial investigating the safety and efficacy of ivermectin mass-drug administration (MDA) for malaria control) to explore participants' views on the trial and the effects of the intervention on individuals and communities.

METHODS

Two participants from each of five villages involved in the trial (two intervention, three control) were purposively selected and trained on the ethical and technical use of cameras. During the final round of the intervention, participants photographed their trial experiences and the MDA effects. Two picture-sharing discussions were conducted to explore the picture content and reasons for their inclusion.

RESULTS

Both intervention and control groups expressed confidence in the trial procedures, with pictures capturing barcode scanning and health assessments, activities reported to provide reassurance and enhance trust. Photos from both groups showed positive outcomes such as improved appetite and fewer mosquitoes. However, photos from the ivermectin group also showed clearing of jiggers and killing of bed bugs. Images of rashes, described as a negative effect of the MDA, were taken by both groups. Pictures of mosquito breeding sites and sources of intestinal worms were also shared by both groups.

CONCLUSION

Photovoice provided valuable insights into trial experiences, intervention effects, and revealed unexpected outcomes, such as killing of bedbugs, that warrant deeper exploration. It exposed broader community concerns of the source of malaria and intestinal worms not addressed by either the intervention or local health authorities.

摘要

背景

由于需要严格的伦理标准和特定的试验程序,在临床试验中评估新的疟疾控制干预措施的可接受性可能很复杂。虽然深入访谈和焦点小组讨论可以提供有用的见解,但一种补充这些方法的更具参与性的数据收集方法是摄影声音法。摄影声音法提供了一种独特的方法,使参与者能够按照自己的方式分享他们的经历和看法。摄影声音法与BOHEMIA临床试验(一项调查伊维菌素大规模药物给药(MDA)用于疟疾控制的安全性和有效性的试验)一起使用,以探讨参与者对试验的看法以及干预措施对个人和社区的影响。

方法

从参与试验的五个村庄中各有目的地挑选两名参与者(两个干预组,三个对照组),并对他们进行相机伦理和技术使用方面的培训。在干预的最后一轮中,参与者拍摄了他们的试验经历和MDA的效果。进行了两次图片分享讨论,以探讨图片内容及其入选原因。

结果

干预组和对照组都对试验程序表示有信心,图片捕捉到了条形码扫描和健康评估,据报道这些活动能让人安心并增强信任。两组的照片都显示出了积极的结果,如食欲改善和蚊子减少。然而,伊维菌素组的照片还显示了沙蚤的清除和臭虫的杀灭。两组都拍摄了被描述为MDA负面影响的皮疹图像。两组还分享了蚊子繁殖地和肠道蠕虫来源的图片。

结论

摄影声音法为试验经历、干预效果提供了有价值的见解,并揭示了一些意外结果,如臭虫的杀灭,值得进一步探索。它暴露了社区对疟疾和肠道蠕虫来源更广泛的担忧,而干预措施或当地卫生当局都未解决这些问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/89abe6281622/12936_2025_5320_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/10e00f7f3e43/12936_2025_5320_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/18300379fb5a/12936_2025_5320_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/7c2f3104711c/12936_2025_5320_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/105c34c73219/12936_2025_5320_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/358cb81005c0/12936_2025_5320_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/c0f92d727ac4/12936_2025_5320_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/62c2030559f5/12936_2025_5320_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/1e3a7a17dca8/12936_2025_5320_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/6dc5a0d22dc0/12936_2025_5320_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/ca3186a01a86/12936_2025_5320_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/1891d82c2ae9/12936_2025_5320_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/cdc2e2e85e8d/12936_2025_5320_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/efba43f19461/12936_2025_5320_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/df69b87eae75/12936_2025_5320_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/541c6ccbce15/12936_2025_5320_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/89abe6281622/12936_2025_5320_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/10e00f7f3e43/12936_2025_5320_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/18300379fb5a/12936_2025_5320_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/7c2f3104711c/12936_2025_5320_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/105c34c73219/12936_2025_5320_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/358cb81005c0/12936_2025_5320_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/c0f92d727ac4/12936_2025_5320_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/62c2030559f5/12936_2025_5320_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/1e3a7a17dca8/12936_2025_5320_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/6dc5a0d22dc0/12936_2025_5320_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/ca3186a01a86/12936_2025_5320_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/1891d82c2ae9/12936_2025_5320_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/cdc2e2e85e8d/12936_2025_5320_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/efba43f19461/12936_2025_5320_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/df69b87eae75/12936_2025_5320_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/541c6ccbce15/12936_2025_5320_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb49/11905568/89abe6281622/12936_2025_5320_Fig16_HTML.jpg

相似文献

1
Through the eyes of the participant: using photovoice to understand the experiences and effects of ivermectin MDA in the context of the BOHEMIA clinical trial in Kwale, Kenya.从参与者的视角:在肯尼亚夸莱的BOHEMIA临床试验背景下,运用照片声音法理解伊维菌素大规模药物驱虫的经历及效果
Malar J. 2025 Mar 12;24(1):79. doi: 10.1186/s12936-025-05320-x.
2
From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia.从知情同意到坚持参与:影响冈比亚大规模药物治疗以消除疟疾中使用伊维菌素的因素。
Malar J. 2021 Apr 26;20(1):198. doi: 10.1186/s12936-021-03732-z.
3
Safety and efficacy of repeat ivermectin mass drug administrations for malaria control (RIMDAMAL II): a phase 3, double-blind, placebo-controlled, cluster-randomised, parallel-group trial.重复使用伊维菌素进行疟疾控制的安全性和有效性(RIMDAMAL II):一项3期、双盲、安慰剂对照、整群随机、平行组试验。
Lancet Infect Dis. 2025 Jul;25(7):737-750. doi: 10.1016/S1473-3099(24)00751-5. Epub 2025 Feb 4.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings.博赫米亚:非洲广泛的一健康内寄生虫杀虫剂疟疾干预-III 期集群随机、开放标签、临床试验,研究伊维菌素大规模药物给药以减少两个非洲环境中的疟疾传播的安全性和有效性。
Trials. 2023 Feb 21;24(1):128. doi: 10.1186/s13063-023-07098-2.
6
Adjunctive ivermectin mass drug administration for malaria control on the Bijagos Archipelago of Guinea-Bissau (MATAMAL): a quadruple-blinded, cluster-randomised, placebo-controlled trial.几内亚比绍比热戈斯群岛采用辅助伊维菌素群体服药法控制疟疾(MATAMAL):一项四盲、整群随机、安慰剂对照试验。
Lancet Infect Dis. 2025 Apr;25(4):424-434. doi: 10.1016/S1473-3099(24)00580-2. Epub 2024 Nov 14.
7
Seeing malaria through the eyes of affected communities: using photovoice to document local knowledge on zoonotic malaria causation and prevention practices among rural communities exposed to Plasmodium knowlesi malaria in Northern Borneo Island.透过受影响社区的视角看疟疾:在北婆罗洲岛,利用影像叙事法记录当地有关动物源疟疾病因和预防知识,这些社区受到间日疟原虫疟疾的影响。
Malar J. 2023 May 26;22(1):166. doi: 10.1186/s12936-023-04603-5.
8
Entomological impact of mass administration of ivermectin and dihydroartemisinin-piperaquine in The Gambia: a cluster-randomized controlled trial.冈比亚大规模使用伊维菌素和双氢青蒿素哌喹的昆虫学影响:一项整群随机对照试验。
Parasit Vectors. 2022 Nov 17;15(1):435. doi: 10.1186/s13071-022-05557-4.
9
Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia.在标准控制干预措施覆盖率高的地区,采用伊维菌素和双氢青蒿素哌喹进行大规模药物给药以防治疟疾:冈比亚的一项整群随机对照试验
Lancet Infect Dis. 2022 Apr;22(4):519-528. doi: 10.1016/S1473-3099(21)00557-0. Epub 2021 Dec 15.
10
Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial.重复使用伊维菌素大规模药物治疗控制疟疾的效果和危害(RIMDAMAL):一项基于群组的随机试验。
Lancet. 2019 Apr 13;393(10180):1517-1526. doi: 10.1016/S0140-6736(18)32321-3. Epub 2019 Mar 14.

引用本文的文献

1
Toxicity of ivermectin to bed bugs (Cimex hemipterus) and risk factors associated with infestation in Kwale County, coastal Kenya.伊维菌素对臭虫(热带臭虫)的毒性以及肯尼亚沿海夸莱县臭虫侵扰的相关风险因素
Parasit Vectors. 2025 Jul 8;18(1):269. doi: 10.1186/s13071-025-06836-6.

本文引用的文献

1
Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control compared with albendazole and no treatment: An open-label randomized controlled trial.单次剂量伊维菌素与三天剂量方案在疟疾媒介控制方面的杀蚊效果和药代动力学比较,与阿苯达唑和不治疗相比:一项开放标签随机对照试验。
Int J Infect Dis. 2024 Nov;148:107236. doi: 10.1016/j.ijid.2024.107236. Epub 2024 Sep 6.
2
Review on the impacts of indoor vector control on domiciliary pests: good intentions challenged by harsh realities.室内病媒控制对家庭害虫影响的综述:美好初衷受到严酷现实的挑战。
Proc Biol Sci. 2024 Aug;291(2027):20240609. doi: 10.1098/rspb.2024.0609. Epub 2024 Jul 24.
3
Comprehension of informed consent and voluntary participation in registration cohorts for phase IIb HIV vaccine trial in Dar Es Salaam, Tanzania: a qualitative descriptive study.
在坦桑尼亚达累斯萨拉姆进行的 IIb 期 HIV 疫苗试验注册队列中,知情同意和自愿参与的理解:一项定性描述性研究。
BMC Med Ethics. 2024 Mar 13;25(1):29. doi: 10.1186/s12910-024-01033-z.
4
Beyond translations, perspectives for researchers to consider to enhance comprehension during consent processes for health research in sub-saharan Africa: a scoping review.超越翻译:撒哈拉以南非洲健康研究知情同意过程中增强理解的研究人员视角:范围综述。
BMC Med Ethics. 2023 Jun 21;24(1):43. doi: 10.1186/s12910-023-00920-1.
5
BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings.博赫米亚:非洲广泛的一健康内寄生虫杀虫剂疟疾干预-III 期集群随机、开放标签、临床试验,研究伊维菌素大规模药物给药以减少两个非洲环境中的疟疾传播的安全性和有效性。
Trials. 2023 Feb 21;24(1):128. doi: 10.1186/s13063-023-07098-2.
6
Community acceptability, participation, and adherence to mass drug administration with primaquine for Plasmodium vivax elimination in Southern Thailand: a mixed methods approach.泰国南部大规模使用伯氨喹啉消除间日疟原虫:采用混合方法评估社区可接受性、参与度和依从不依从不依从性。
Malar J. 2023 Jan 13;22(1):17. doi: 10.1186/s12936-023-04443-3.
7
House screening for malaria control: views and experiences of participants in the RooPfs trial.疟疾控制的家庭筛查:RooPfs 试验参与者的观点和经验。
Malar J. 2022 Oct 21;21(1):294. doi: 10.1186/s12936-022-04321-4.
8
Treatment of Pregnant Women with Ivermectin during Mass Drug Distribution: Time to Investigate Its Safety and Potential Benefits.大规模药物分发期间用伊维菌素治疗孕妇:是时候研究其安全性和潜在益处了。
Pathogens. 2021 Dec 8;10(12):1588. doi: 10.3390/pathogens10121588.
9
From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia.从知情同意到坚持参与:影响冈比亚大规模药物治疗以消除疟疾中使用伊维菌素的因素。
Malar J. 2021 Apr 26;20(1):198. doi: 10.1186/s12936-021-03732-z.
10
Assessment of the Acceptability of Testing and Treatment during a Mass Drug Administration Trial for Malaria in Zambia Using Mixed Methods.采用混合方法评估赞比亚大规模药物治疗疟疾试验中检测和治疗的可接受性。
Am J Trop Med Hyg. 2020 Aug;103(2_Suppl):28-36. doi: 10.4269/ajtmh.19-0663.